KELIX Bio, a subsidiary of Mubadala Investment Company, has completed its acquisition of DiabTec, a biomanufacturing facility previously owned by Julphar, one of the UAE’s largest pharmaceutical ...

KELIX bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec LLC, a subsidiary of Julphar. This acquisition strengthens ...

Getir founders allege Mubadala breached restructuring agreement Mubadala claims founders failed to complete June agreement Mubadala says it will present new plan to Getir shareholders in coming ...

A strategic move that further supports Mubadala’s efforts to advance the UAE's life sciences sector Following the acquisition of four GlobalOne Healthcare Holding assets, this transaction represents ...

UAE - Kelix bio, wholly owned by Mubadala Investment Company, an Abu Dhabi sovereign investor, has completed the acquisition of DiabTec, a subsidiary of Julphar. This acquisition strengthens ...

Kelix bio, an emerging markets-focused specialty generic biopharmaceutical company has struck its fifth strategic deal since its acquisition by Abu Dhabi sovereign investor Mubadala Investment Company ...

Getir’s founding team had previously clashed with investors, primarily Mubadala, over the company’s strategy and costs. Its valuation plunged to $2.5 billion in 2023 from its peak of $11.8 ...

RIYADH, Jan 19 (Reuters) - Turkish grocery delivery company Getir and its biggest shareholder, Abu Dhabi state investment fund Mubadala, remained at odds on Sunday over a restructuring plan which ...

(Bloomberg) -- Private credit has been the best-performing asset class for Mubadala Investment Co. for three years in a row, according to the Abu Dhabi sovereign wealth fund’s deputy group chief ...